Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
- 주제(키워드) Papillomavirus Vaccines , Practice Guidelines , Female , Male
- 주제(기타) Oncology; Obstetrics & Gynecology
- 설명문(일반) [Min, Kyung-Jin; Lee, Jae-Koran] Korea Univ, Coll Med, Dept Obstet & Gynecol, Med Ctr, 148 Gurodong Ro, Seoul 08308, South Korea; [Kwon, Sang-Hoon] Keimyung Univ, Dept Obstet & Gynecol, Sch Med, Daegu, South Korea; [Kim, Kidong] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea; [Kim, Sunghoon] Yonsei Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Kim, Hyun Jung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Seong, Seok Ju] CHA Univ, CHA Gangnam Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Song, Yong Jung] Pusan Natl Univ, Dept Obstet & Gynecol, Sch Med, Yangsan, South Korea; [Lee, Keun Ho] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Shin-Wha; Kim, Young-Tak] Univ Ulsan, Asan Med Ctr, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Lee, Jeong-Won] Sungkyunkwan Univ, Samsung Med Ctr, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Chang, Suk-Joon] Ajou Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Sch Med, Suwon, South Korea; [Ju, Woong] Ewha Womans Univ, Sch Med, Dept Obstet & Gynecol, Mokdong Hosp, Seoul, South Korea
- 등재 SCIE, SCOPUS, KCI등재
- OA유형 gold, Green Published, Green Submitted
- 발행기관 KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
- 발행년도 2019
- URI http://www.dcollection.net/handler/ewha/000000160020
- 본문언어 영어
- Published As http://dx.doi.org/10.3802/jgo.2019.30.e31
- PubMed https://pubmed.ncbi.nlm.nih.gov/30740959
초록/요약
In 2016, 9-valent human papillomavirus (HPV) vaccine has been newly introduced in Korea, thus the need to develop recommendations for the vaccine has raised. Until we decide to develop a guideline, no further studies on the bi-valent or quadri-valent HPV vaccine have been announced. We searched and reviewed the literatures focused on the efficacy of 9-valent HPV vaccine, the ideal age of 3-dose schedule vaccination, the efficacy of 9-valent HPV vaccine in middle-aged women, the efficacy of the 2-dose schedule vaccination, the safety of 9-valent HPV vaccine, the possibility of additional 9-valent HPV vaccination, and cross-vaccination of 9-valent HPV vaccine. So, Korean Society of Gynecologic Oncology (KSGO) developed a guideline only for 9-valent HPV vaccine.
more